PTP Accounts Production v24.1.0.578 08390066 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Fair value model Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C & D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh083900662023-03-31083900662024-03-31083900662023-04-012024-03-31083900662022-03-31083900662022-04-012023-03-31083900662023-03-3108390066ns14:PoundSterling2023-04-012024-03-3108390066ns10:Director12023-04-012024-03-3108390066ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3108390066ns10:SmallEntities2023-04-012024-03-3108390066ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3108390066ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3108390066ns10:FullAccounts2023-04-012024-03-3108390066ns10:OrdinaryShareClass12023-04-012024-03-3108390066ns10:OrdinaryShareClass22023-04-012024-03-3108390066ns10:OrdinaryShareClass32023-04-012024-03-3108390066ns10:Director22023-04-012024-03-3108390066ns10:RegisteredOffice2023-04-012024-03-3108390066ns5:CurrentFinancialInstruments2024-03-3108390066ns5:CurrentFinancialInstruments2023-03-3108390066ns5:ShareCapital2024-03-3108390066ns5:ShareCapital2023-03-3108390066ns5:RetainedEarningsAccumulatedLosses2024-03-3108390066ns5:RetainedEarningsAccumulatedLosses2023-03-3108390066ns5:FurnitureFittings2023-04-012024-03-3108390066ns5:PlantMachinery2023-03-3108390066ns5:FurnitureFittings2023-03-3108390066ns5:PlantMachinery2023-04-012024-03-3108390066ns5:PlantMachinery2024-03-3108390066ns5:FurnitureFittings2024-03-3108390066ns5:PlantMachinery2023-03-3108390066ns5:FurnitureFittings2023-03-3108390066ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3108390066ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3108390066ns5:DeferredTaxation2023-03-3108390066ns5:DeferredTaxation2023-04-012024-03-3108390066ns5:DeferredTaxation2024-03-3108390066ns10:OrdinaryShareClass12024-03-3108390066ns10:OrdinaryShareClass22024-03-3108390066ns10:OrdinaryShareClass32024-03-3108390066ns5:RetainedEarningsAccumulatedLosses2023-03-3108390066ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-31
REGISTERED NUMBER: 08390066





















Unaudited Financial Statements for the Year Ended 31 March 2024

for

WEST MIDLANDS UROLOGY SERVICES LIMITED

WEST MIDLANDS UROLOGY SERVICES LIMITED (Registered number: 08390066)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


WEST MIDLANDS UROLOGY SERVICES LIMITED

Company Information
for the Year Ended 31 March 2024







DIRECTORS: Dr B D Sarmah
Mrs P Sarmah





REGISTERED OFFICE: 19 Poundley Close
Castle Bromwich
Birmingham
West Midlands
B36 9SZ





REGISTERED NUMBER: 08390066






WEST MIDLANDS UROLOGY SERVICES LIMITED (Registered number: 08390066)

Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 8,581 7,661
Investment property 5 190,000 190,000
198,581 197,661

CURRENT ASSETS
Debtors 6 9,240 12,987
Cash at bank 189,166 160,453
198,406 173,440
CREDITORS
Amounts falling due within one year 7 102,683 93,507
NET CURRENT ASSETS 95,723 79,933
TOTAL ASSETS LESS CURRENT
LIABILITIES

294,304

277,594

PROVISIONS FOR LIABILITIES 8 7,380 7,184
NET ASSETS 286,924 270,410

CAPITAL AND RESERVES
Called up share capital 9 200 200
Retained earnings 10 286,724 270,210
SHAREHOLDERS' FUNDS 286,924 270,410

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WEST MIDLANDS UROLOGY SERVICES LIMITED (Registered number: 08390066)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 January 2025 and were signed on its behalf by:





Dr B D Sarmah - Director


WEST MIDLANDS UROLOGY SERVICES LIMITED (Registered number: 08390066)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

WEST MIDLANDS UROLOGY SERVICES LIMITED is a private company, limited by shares , registered in Not specified/Other. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

WEST MIDLANDS UROLOGY SERVICES LIMITED (Registered number: 08390066)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

4. TANGIBLE FIXED ASSETS
Fixtures
and
Chattels fittings Totals
£    £    £   
COST
At 1 April 2023 2,001 15,901 17,902
Additions - 2,443 2,443
At 31 March 2024 2,001 18,344 20,345
DEPRECIATION
At 1 April 2023 1,245 8,996 10,241
Charge for year 113 1,410 1,523
At 31 March 2024 1,358 10,406 11,764
NET BOOK VALUE
At 31 March 2024 643 7,938 8,581
At 31 March 2023 756 6,905 7,661

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 April 2023
and 31 March 2024 190,000
NET BOOK VALUE
At 31 March 2024 190,000
At 31 March 2023 190,000

The fair value of the investment property has been arrived at on the basis of a valuation carried out on 31 March 2024 by the director. The valuation was made on an open market value basis by reference to market evidence of transaction prices of similar properties.

Fair value at 31 March 2024 is represented by:
£   
Valuation in 2019 18,727
Cost 171,273
190,000

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 6,511 12,013
Other debtors 2,729 974
9,240 12,987

WEST MIDLANDS UROLOGY SERVICES LIMITED (Registered number: 08390066)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade creditors (1 ) (1 )
Taxation and social security 6,071 6,093
Other creditors 96,613 87,415
102,683 93,507

8. PROVISIONS FOR LIABILITIES
31.3.24 31.3.23
£    £   
Deferred tax
Deferred tax 3,822 3,626
Deferred tax Invested Property 3,558 3,558
7,380 7,184

Deferred
tax
£   
Balance at 1 April 2023 7,184
Charge to Income Statement during year 196
Balance at 31 March 2024 7,380

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
152 Ordinary A 1 152 152
28 Ordinary B 1 28 28
20 Ordinary C & D 1 20 20
200 200

10. RESERVES
Retained
earnings
£   

At 1 April 2023 270,210
Profit for the year 26,514
Dividends (10,000 )
At 31 March 2024 286,724

11. ULTIMATE CONTROLLING PARTY

The director is the controlling party.